FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41525611000001107: Abiraterone 250mg tablets (Cipla EU Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2909781000001111 Abiraterone 250mg tablets (Cipla EU Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2909791000001113 Abiraterone 250mg tablets (Cipla EU Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abiraterone 250mg tablets (Cipla EU Ltd) Is a Abiraterone 250mg tablets true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Has specific active ingredient Abiraterone acetate true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has AMP True Abiraterone 250mg tablets (Cipla EU Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start